Hepatology

The results demonstrated a high probability, 97.3%, that shorter durations of antibiotic prophylaxis, including no treatment, were noninferior to longer durations for all-cause mortality.

Discover a study showing that post-treatment AFP levels help predict hepatocellular carcinoma risk in chronic hepatitis C patients after antiviral therapy.

Potential mechanisms behind BSV’s protective effect may mirror those described for tenofovir-based therapies, such as modulation of inflammatory and oncogenic pathways.

Emerging evidence points to the role of CD4+ T cell subsets in fuelling MAFLD-related inflammation and fibrosis.

Learn how new research links major air pollutants with increased NAFLD risk, urging broader public health focus.

Understand how paternal hepatitis B has no significant effect on ART pregnancy or live birth outcomes.

Combined liver transplant and sleeve gastrectomy yield lasting weight loss and fewer metabolic complications in patients with obesity.

The team concluded that CLD remains a major health burden in Thailand, highlighting the need for strong prevention strategies, early diagnosis, and equitable access to effective therapies.